DRP2 inhibitors belong to a chemical class of compounds specifically designed to target and modulate the activity of Dihydropyrimidinase-related protein 2 (DRP2), a crucial protein involved in various cellular processes. DRP2, also known as CRMP2 (Collapsin Response Mediator Protein 2), plays a vital role in neurite outgrowth, axonal guidance, and microtubule dynamics, making it an attractive target for research aimed at understanding fundamental cellular functions. These inhibitors are primarily utilized in laboratory settings to investigate the intricate signaling pathways and mechanisms associated with DRP2 and its involvement in neuronal development and plasticity.
Structurally, DRP2 inhibitors can vary widely, with diverse chemical backbones and functional groups. They are typically designed to interfere with the function or regulation of DRP2 through various mechanisms. Some inhibitors may directly bind to DRP2, affecting its conformation or post-translational modifications, while others may act indirectly by targeting upstream or downstream components of DRP2-associated pathways. By modulating DRP2 activity, these compounds enable researchers to explore the precise roles of DRP2 in cellular processes, such as cytoskeletal organization and synaptic plasticity. This class of inhibitors has proven invaluable in elucidating the intricate interplay between DRP2 and other proteins involved in neurodevelopment and neurodegenerative disorders, contributing to a deeper understanding of neuronal biology.In summary, DRP2 inhibitors constitute a diverse chemical class employed primarily for scientific research purposes, enabling the study of DRP2's involvement in fundamental cellular processes. These compounds vary in structure and mechanism of action but share the common goal of facilitating investigations into the roles of DRP2 in neurite outgrowth, axonal guidance, and other neurobiological phenomena. Their significance lies in their ability to uncover the complexities of DRP2-associated pathways and provide insights into the molecular underpinnings of neuronal development and function.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fingolimod | 162359-55-9 | sc-507334 | 10 mg | $160.00 | ||
Fingolimod modulates sphingosine-1-phosphate receptors, preventing the egress of lymphocytes from lymph nodes, and thus reducing the infiltration of inflammatory cells into the central nervous system. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a selective inhibitor of LRRK2, a kinase associated with Parkinson's disease, potentially reducing the aberrant phosphorylation of DRP2. | ||||||
NVP-BHG712 | 940310-85-0 | sc-364554 sc-364554A | 5 mg 50 mg | $232.00 $1764.00 | ||
NVP-BHG712 inhibits vascular endothelial growth factor receptor (VEGFR) tyrosine kinases, which may indirectly impact DRP2 function by affecting angiogenesis. | ||||||
YM 155 | 781661-94-7 | sc-364661 sc-364661A | 5 mg 25 mg | $132.00 $507.00 | 3 | |
YM-155 suppresses survivin, an anti-apoptotic protein. While not directly targeting DRP2, it could influence cell survival pathways involving DRP2 indirectly. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide inhibits NF-kappa B activation, which may reduce inflammation-induced changes in DRP2 expression and function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor, which can affect gene expression, potentially influencing DRP2 levels indirectly. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine (Seliciclib) inhibits CDKs, leading to cell cycle arrest. This could affect cell proliferation and indirectly influence DRP2 expression and function. | ||||||
MLN 8054 | 869363-13-3 | sc-484828 | 5 mg | $398.00 | ||
MLN8054 targets Aurora A kinase, potentially impacting the cell cycle and mitosis, which might indirectly affect DRP2 regulation and function. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
Dorsomorphin is an AMP-activated protein kinase (AMPK) inhibitor, which may affect energy metabolism and cellular processes related to DRP2 indirectly. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of NF-kappa B activation, potentially influencing inflammation-induced changes in DRP2 expression and function. | ||||||